Answers are grounded in this paper and cite their sources.
Pain frequently persists in rheumatoid arthritis (RA), psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA) despite effective control of inflammation. This scoping review mapped evidence linking peripheral inflammation to altered nociceptive processing, neuroimmune signaling, endogenous opioid and stress systems, and reward circuitry, distinguishing direct disease-specific evidence from indirect or preclinical data. Following Joanna Briggs Institute methodology and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR), we searched six databases from inception to 29 August 2026. We charted 303 disease-specific human studies and 135 indirect human studies across seven mechanistic bridges, classified by translational proximity. Pain–inflammation discordance had the most consistent direct evidence, followed by widespread hypersensitivity in quantitative sensory testing, mainly from RA. Impaired endogenous pain inhibition was moderately supported and pain–depression associations were well replicated, whereas glial and endogenous-opioid mechanisms had limited disease-specific evidence. Mesolimbic reward, dynorphin–kappa opioid, and relief-driven reinforcement mechanisms had minimal direct evidence despite robust preclinical and, for reward circuitry, indirect human evidence. PsA and axSpA were underrepresented. The evidence forms a gradient, most consistent for clinical pain–inflammation discordance and increasingly provisional toward central and reward-related mechanisms. These findings identify the weakest translational links and support phenotype-stratified trials and precision-analgesia research.
No takes yet. Share an insight, caveat, or question.
Nicolas et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: